Lipid rafts and caveolae and their role in compartmentation of redox signaling

Antioxidants and Redox Signaling

Volumn 11, Issue 6, 2009, Pages 1357-1372

  Patel, Hemal H ^a   Insel, Paul A ^b,c  

^a Departments of 1anesthesiology

^b University of California ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE; OXYGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

CAVEOLA; CELL COMPARTMENTALIZATION; CELL ORGANELLE; CELLULAR DISTRIBUTION; HUMAN; LIPID RAFT; MOLECULAR DYNAMICS; MOLECULE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; CAVEOLAE; CELL MEMBRANE; HUMANS; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 65149085667     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2365     Document Type: Review

References (180)

1. Abrahams PH, Day A, and Allt G. Schwann cell plasma membrane changes induced by nerve crush. A freeze-fracture study. Ada Neuropathol 50: 85-90, 1980.
2. Achcar RO, Demura Y, Rai PR, Taraseviciene-Stewart L, Kasper M, Voelkel NF, and Cool CD. Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension. Chest 129: 696-705, 2006.
3. Ayuyan AG and Cohen FS. Lipid peroxides promote large rafts: Effects of excitation of probes in fluorescence microscopy and electrochemical reactions during vesicle formation. Biophys } 91: 2172-2183, 2006.
4. Babior BM. NADPH oxidase: An update. Blood 93: 1464-1476, 1999.
5. Babuke T and Tikkanen R. Dissecting the molecular function of reggie/flotillin proteins. Eur J Cell Biol 86: 525-532, 2007.
6. Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, Fratto P, Polvani G, Vitali E, Parolari A, Mussoni L, and Tremoli E. Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics 6: 1976-1988, 2006.
7. Bartz R, Zhou J, Hsieh JT, Ying Y, Li W, and Liu P. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Int J Cancer 122: 520-525, 2008.
8. Becher A and Mcllhinney RA. Consequences of lipid raft association on G-protein-coupled receptor function. Bio-chem Soc Symp 72: 151-164, 2005.
9. Bist A, Fielding PE, and Fielding CJ. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci USA 94: 10693-10698, 1997.
10. Blonder J, Terunuma A, Conrads TP, Chan KC, Yee C, Lucas DA, Schaefer CF, Yu LR, Issaq HJ, Veenstra TD, and Vogel JC. A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry. J Invest Dermatol 123: 691-699, 2004.
11. Callera GE, Montezano AC, Yogi A, Tostes RC, and Touyz RM. Vascular signaling through cholesterol-rich domains: implications in hypertension. Curr Opin Nephrol Hypertens 16: 90-104, 2007.
12. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
13. Chini B and Parenti M. G-protein coupled receptors in lipid rafts and caveolae: How, when and why do they go there? J Mol Endocrinol 32: 325-338, 2004.
14. Cohen AW, Hnasko R, Schubert W, and Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
15. Costello BR and Shafiq SA. Freeze-fracture study of muscle plasmalemma in normal and dystrophic chickens. Muscle Nerve 2: 191-201, 1979.
16. Couet J, Li S, Okamoto T, Ikezu T, and Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Bio Chem 272: 6525-6533, 1997.
17. Danielsen EM and van Deurs B. A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncave-olar microdomains at the apical surface of fetal intestinal epithelial cells. J Cell Biol 131: 939-950, 1995.
18. Das K, Lewis RY, Scherer PE, and Lisanti MP. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo, J Biol Chem 274: 18721-18728, 1999.
19. David A, Fridlich R, and Aviram I. The presence of membrane Proteinase 3 in neutrophil lipid rafts and its coloca-lization with FcgammaRIΠb and cytochrome b558. Exp Cell Res 308: 156-165, 2005.
20. Dietzen DJ, Hastings WR, and Lublin DM. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 270: 6838-6842, 1995.
21. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lau-terbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, and Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
22. Dudzinski DM and Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 75: 247-260, 2007.
23. Durante W, Kroll MH, Christodoulides N, Peyton KJ, and Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80: 557-564, 1997.
24. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, and Schnitzer JE. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 22: 985-992, 2004.
25. Engelman JA, Zhang X, Galbiati F, Volonté D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, and Lisanti MP. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet 63: 1578-1587,1998.
26. Engelman JA, Zhang XL, and Lisanti MP. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 448: 221-230, 1999.
27. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, and Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271: 22810-22814, 1996.
28. Feron O and Kelly RA. The Caveolar Paradox: Suppressing, Inducing, and Terminating eNOS Signaling. Circ Res 88: 129-131, 2001.
29. Fiedler K, Parton RG, Kellner R, Etzold T, and Simons K. VIP36, a novel component of glycolipid rafts and exocytic carrier vesicles in epithelial cells. EMBO J13: 1729-1740, 1994.
30. Fielding CJ, Bist A, and Fielding PE. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94: 3753-3758, 1997.
31. Foster LJ, De Hoog CL, and Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100: 5813-5818, 2003.
32. Frick M, Bright NA, Riento K, Bray A, Merrified C, and Nichols BJ. Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr Biol 17: 1151-1156, 2007.
33. Fridlich R, David A, and Aviram I. Membrane proteinase 3 and its interactions within microdomains of neutrophil membranes. J Cell Biochem 99: 117-125, 2006.
34. Fulop T, Larbi A, Douziech N, Fortin C, Guerard KP, Lesur O, Khalil A, and Dupuis G. Signal transduction and functional changes in neutrophils with aging. Aging Cell 3: 217-226, 2004.
35. Galbiati F, Razani B, and Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 106: 403-411, 2001.
36. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, and Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1997.
37. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996.
38. Ge S, Song L, Serwanski DR, Kuziel WA, and Pachter JS. Transcellular transport of CCL2 across brain microvascular endothelial cells. J Neurochem 104: 1219-1232, 2008.
39. Ghafourifar P, Bringold U, Klein SD, and Richter C. Mi-tochondrial nitric oxide synthase, oxidative stress and ap-optosis. Biol Signals Receγt 10: 57-65, 2001.
40. Gherghiceanu M and Popescu LM. Electron microscope tomography: further demonstration of nanocontacts between caveolae and smooth muscle sarcoplasmic reticu-lum. J Cell Mol Med 11: 1416-1418, 2007.
41. Ghosh S, Gachhui R, Crooks C, Wu C, Lisanti MP, and Stuehr DJ. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem 273: 22267-22271, 1998.
42. Goodsaid-Zalduondo F, Rintoul DA, Carlson JC, and Hansel W. Luteolysis-induced changes in phase composition and fluidity of bovine luteal cell membranes. Proc Natl Acad Sci USA 79: 4332-4336, 1982.
43. Grande-Garcia A and Del Pozo MA. Caveolin-1 in cell polarization and directional migration. Eur J Cell Biol 87: 641-647, 2008.
44. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, and del Pozo MA. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol 177: 683-694, 2007.
45. Guichard C, Pedruzzi E, Dewas C, Fay M, Pouzet C, Bens M, Vandewalle A, Ogier-Denis E, Gougerot-Pocidalo MA, and Elbim C. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 280: 37021-37032, 2005.
46. Gullestad L, Oie E, Ueland T, Yndestad A, and Aukrust P. The role of statins in heart failure. Fund Clin Pharmacol 21: 35-40, 2007.
47. Han W, Li H, Villar VA, Pascua AM, Dajani MI, Wang X, Natarajan A, Quinn MT, Felder RA, Jose PA, and Yu P. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 51: 481-487, 2008.
48. Harder T, Scheiffele P, Verkade P, and Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 141: 929-942, 1998.
49. Harder T and Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 9: 534-542, 1997.
50. Hayashi T, Juliet PA, Miyazaki A, Ignarro LJ, and Iguchi A. High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis. Biochim Biophys Acta 1772: 364-372, 2007.
51. Head BP and Insel PA. Do caveolins regulate cells by actions outside of caveolae? Trends Cell Biol 17: 51-57, 2007.
52. Head BP, Patel HH, Tsutsumi YM, Hu Y, Mejia T, Mora RC, Insel PA, Roth DM, Drummond JC, and Patel PM. Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death. FASEB J 22: 828-840, 2008.
53. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Noxl and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
54. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF, and Parton RG. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132: 113-124, 2008.
55. Hnasko R and Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Intern 3: 445-464, 2003.
56. Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y, Ishikawa Y, Insel PA, and Roth DM. Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol 44: 123-130, 2008.
57. Hu G, Ye RD, Dinauer MC, Malik AB, and Minshall RD. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am f Physiol Lung Cell Mol Physiol 294: L178-186, 2008.
58. Insel PA and Patel HH. Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'? Br J Pharmacol 150: 251-254, 2007.
59. Insel PA and Patel HH. Membrane rafts and caveolae in cardiovascular signaling. Curr Opin Nephrol Hypertens 18: 50-56, 2009.
60. Iwabuchi K, Prinetti A, Sonnino S, Mauri L, Kobayashi T, Ishii K, Kaga N, Murayama K, Kurihara H, Nakayama H, Yoshizaki F, Takamori K, Ogawa H, and Nagaoka I. Involvement of very long fatty acid-containing lacto-sylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconj J 25: 357-374, 2008.
61. Iwakiri Y, Satoh A, Chatterjee S, Toomre DK, Chalouni CM, Fulton D, Groszmann RJ, Shah VH, and Sessa WC. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci USA 103: 19777-19782, 2006.
62. Jacobson K, Mouritsen OG, and Anderson RG. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9: 7-14, 2007.
63. Jansen M, Pietiainen VM, Polonen H, Rasilainen L, Koi-vusalo M, Ruotsalainen U, Jokitalo E, and Ikonen E. Cholesterol substitution increases the structural heterogeneity of caveolae. J Biol Chem 283: 14610-14618, 2008.
64. Jin S, Zhang Y, Yi F, and Li PL. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 28: 485-490, 2008.
65. Jin Y, Kim HP, Chi M, Ifedigbo E, Ryter SW, and Choi AM. Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am J Respir Cell Mol Biol 39: 171-179, 2008.
66. Jung NH, Kim HP, Kim BR, Cha SH, Kim GA, Ha H, Na YE, and Cha YN. Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells. IUBMB Life 55: 525-532, 2003.
67. Karnovsky MJ, Kleinfeld AM, Hoover RL, and Klausner RD. The concept of lipid domains in membranes. J Cell Biol 94: 1-6, 1982.
68. Kenworthy AK, Petranova N, and Edidin M. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11: 1645-1655, 2000.
69. Kim HA, Kim KH, and Lee RA. Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp Mol Pathol 80: 165-170, 2006.
70. Kim HP, Ryter SW, and Choi AM. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 46: 411-449, 2006.
71. Kim HP, Wang X, Galbiati F, Ryter SW, and Choi AM. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB } 18: 1080-1089, 2004.
72. Kim HP, Wang X, Nakao A, Kim SI, Murase N, Choi ME, Ryter SW, and Choi AM. Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc Natl Acad Sci USA 102: 11319-11324, 2005.
73. Kiss E, Nagy P, Balogh A, Szollosi J, and Matko J. Cyto-metry of raft and caveola membrane microdomains: From flow and imaging techniques to high throughput screening assays. Cytometry A 73: 599-614, 2008.
74. Klausner RD, Kleinfeld AM, Hoover RL, and Karnovsky MJ. Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis. J Biol Chem 255: 1286-1295, 1980.
75. Klinge CM, Wickramasinghe NS, Ivanova MM, and Dougherty SM. Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB } 22: 2185-2197, 2008.
76. Kogo H and Fujimoto T. Caveolin-1 isoforms are encoded by distinct mRNAs. Identification Of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett 465: 119-123, 2000.
77. Koneru S, Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Han Z, Maulik G, Das DK, and Maulik N. Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol 292: H2060-2072, 2007.
78. Krajewska WM and Maslowska I. Caveolins: Structure and function in signal transduction. Cell Mol Biol Lett 9:195-220, 2004.
79. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, and Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. / Cell Biol 118: 1003-1014, 1992.
80. Lai EC. Lipid rafts make for slippery platforms. J Cell Biol 162: 365-370, 2003.
81. Li L and Moore PK. Putative biological roles of hydrogen sulfide in health and disease: A breath of not so fresh air? Trends Pharmacol Sci 29: 84-90, 2008.
82. Li PL, Zhang Y, and Yi F. Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal 9: 1457-1470, 2007.
83. Li S, Seitz R, and Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo, J Biol Chem 271: 3863-3868, 1996.
84. Lingwood D and Simons K. Detergent resistance as a tool in membrane research. Nat Protoc 2: 2159-2165, 2007.
85. Liu L and Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem 283: 4314-4322, 2008.
86. Lopez-Sepulveda R, Jimenez R, Romero M, Zarzuelo MJ, Sanchez M, Gomez-Guzman M, Vargas F, O'Valle F, Zarzuelo A, Perez-Vizcaino F, and Duarte J. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension 51: 1088-1095, 2008.
87. Lu SP, Lin Feng MH, Huang HL, Huang YC, Tsou WI, and Lai MZ. Reactive oxygen species promote raft formation in T lymphocytes. Free Radic Biol Med 42: 936-944, 2007.
88. McMahon KA, Zhu M, Kwon SW, Liu P, Zhao Y, and Anderson RG. Detergent-free caveolae proteome suggests an interaction with ER and mitochondria. Proteomics 6: 143-152, 2006.
89. Michel V and Bakovic M. Lipid rafts in health and disease. Biol Cell 99: 129-140, 2007.
90. Milovanova T, Chatterjee S, Hawkins BJ, Hong N, Sorokina EM, Debolt K, Moore JS, Madesh M, and Fisher AB. Caveolae are an essential component of the pathway for endothelial cell signaling associated with abrupt reduction of shear stress. Biochim Biophys Acta 1783: 1866-1875, 2008.
91. Minshall RD and Malik AB. Transport across the endo-thelium: regulation of endothelial permeability. Handb Exp Pharmacol: 107-144, 2006.
92. Mishra S and Joshi PG. Lipid raft heterogeneity: An enigma. J Neurochem 103: 135-142, 2007.
93. Mongrand S, Morel J, Laroche J, Claverol S, Carde JP, Hartmann MA, Bonneu M, Simon-Plas F, Lessire R, and Bessoule JJ. Lipid rafts in higher plant cells: Purification and characterization of Triton X-100-insoluble micro-domains from tobacco plasma membrane. J Biol Chem 279: 36277-36286, 2004.
94. Monier S, Parton RG, Vogel F, Behlke J, Henske A, and Kurzchalia TV. VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol Biol Cell 6: 911-927, 1995.
95. Mouillet-Richard S, Schneider B, Pradines E, Pietri M, Er-monval M, Grassi J, Richards JG, Mutel V, Launay JM, and Kellermann O. Cellular prion protein signaling in seroto-nergic neuronal cells. Ann NY Acad Sci 1096: 106-119, 2007.
96. Mukherjee S, Tessema M, and Wandinger-Ness A. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function. Circ Res 98: 743-756, 2006.
97. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, and Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92: 10339-10343, 1995.
98. Murata T, Lin MI, Huang Y, Yu J, Bauer PM, Giordano FJ, and Sessa WC. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204: 2373-2382, 2007.
99. Nagatsuka Y and Hirabayashi Y. Phosphatidylglucoside: A new marker for lipid rafts. Biochim Biophys Acta 1780: 405-409, 2008.
100. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Drain PF, Wang X, Sasidhar M, Nabel EG, Takahashi T, Lukacs NW, Ryter SW, Morita K, and Choi AM. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp Med 203: 2377-2389, 2006.
101. Nichols B. Caveosomes and endocytosis of lipid rafts. J Cell Sci 116: 4707-4714, 2003.
102. Nourissat P, Travert M, Chevanne M, Tekpli X, Rebillard A, Le Moigne-Muller G, Rissel M, Cillard J, Dimanche-Boitrel MT, Lagadic-Gossmann D, and Sergent O. Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering. Hepatology 47: 59-70, 2008.
103. Oguchi K and Tsukagoshi H. An electron-microscopic study of the T-system in progressive muscular dystrophy (Duchenne) using lanthanum. J Neurol Sci 44: 161-168, 1980.
104. Ostrom RS and Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br f Pharmacol 143: 235-245, 2004.
105. Ostrom RS and Liu X. Detergent and detergent-free methods to define lipid rafts and caveolae. Methods Mol Biol 400: 459-468, 2007.
106. Owen DM, Neil MA, French PM, and Magee AI. Optical techniques for imaging membrane lipid microdomains in living cells. Semin Cell Dev Biol 18: 591-598, 2007.
107. Ozawa K, Whalen EJ, Nelson CD, Mu Y, Hess DT, Lefko-witz RJ, and Stamler JS. S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell 31: 395-405, 2008.
108. Palade G. Fine structure of blood capillaries. J Appl Phys 24: 1424, 1953.
109. Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, Souza APD, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, and Lisanti MP. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry 42: 15124-15131, 2003.
110. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, and Lisanti MP. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160: 2207-2217, 2002.
111. Park SC, Cho KA, Jang IS, Kim KT, and Ryu SJ. Functional efficiency of the senescent cells: replace or restore? Ann NY Acad Sci 1019: 309-316, 2004.
112. Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, Rodriguez-Boulan E, Peschle C, and Lisanti MP. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J Biol Chem 274: 25718-25725, 1999.
113. Patel HH, Murray F, and Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 48: 359-391, 2008.
114. Patel HH, Murray F, and Insel PA. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol: 167-184, 2008.
115. Patel HH, Tsutsumi YM, Head BP, Niesman IR, Jennings M, Horikawa Y, Huang D, Moreno AL, Patel PM, Insel PA, and Roth DM. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1. FASEB ] 21: 1565-1574, 2007.
116. Patel HH, Zhang S, Murray F, Suda RY, Head BP, Yo-koyama U, Swaney JS, Niesman IR, Schermuly RT, Pull-amsetti SS, Thistlethwaite PA, Miyanohara A, Farquhar MG, Yuan JX, and Insel PA. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB } 21: 2970-2979, 2007.
117. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 1785: 182-206, 2008.
118. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, and Berk BC. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res 85: 29-37, 1999.
119. Pietri M, Caprini A, Mouillet-Richard S, Pradines E, Er-monval M, Grassi J, Kellermann O, and Schneider B. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells. J Biol Chem 281: 28470-28479, 2006.
120. Pike LJ. Growth factor receptors, lipid rafts and caveolae: An evolving story. Biochim Biophys Acta 1746: 260-273, 2005.
121. Pike LJ. Lipid rafts: Bringing order to chaos. J Lipid Res 44: 655-667, 2003.
122. Pike LJ. Lipid rafts: Heterogeneity on the high seas. Biochem J 378: 281-292, 2004.
123. Pike LJ. Rafts defined: A report on the Keystone Symposium on lipid rafts and cell function. J Lipid Res 47: 1597-1598, 2006.
124. Pike LJ, Han X, Chung K-N, and Gross RW. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: A quantitative electrospray ionization/mass spectro-metric analysis. Biochemistry 41: 2075-2088, 2002.
125. Pilch PF, Souto RP, Liu L, Jedrychowski MP, Berg EA, Costello CE, and Gygi SP. Cellular spelunking: exploring adipocyte caveolae. J Lipid Res 48: 2103-2111, 2007.
126. Pritchard KA, Ackerman AW, Ou J, Curtis M, Smalley DM, Fontana JT, Stemerman MB, and Sessa WC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med 33: 52-62, 2002.
127. Ratajczak P, Damy T, Heymes C, Oliviero P, Marotte F, Robidel E, Sercombe R, Boczkowski J, Rappaport L, and Samuel JL. Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Cardiovasc Res 57: 358-369, 2003.
128. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H, Jr., Kneitz B, Lagaud G, Christ GJ, Edel-mann W, and Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
129. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H, Jr., Knietz B, Lagaud G, Christ GJ, Edel-mann W, and Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyper- proliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
130. Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Jr., Christ GJ, Edelmann W, and Lisanti MP. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22: 2329-2344, 2002.
131. Razzaq TM, Ozegbe P, Jury EC, Sembi P, Blackwell NM, and Kabouridis PS. Regulation of T-cell receptor signalling by membrane microdomains. Immunology 113: 413-426, 2004.
132. Rodgers W, Farris D, and Mishra S. Merging complexes: properties of membrane raft assembly during lymphocyte signaling. Trends Immunol 26: 97-103, 2005.
133. Rodriguez-Feo JA, Hellings WE, Moll FL, De Vries JP, van Middelaar BJ, Algra A, Sluijter J, Velema E, van der Broek T, Sessa WC, De Kleijn DP, and Pasterkamp G. Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease. PLoS ONE 3: e2612, 2008.
134. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, and Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682, 1992.
135. Sage MD and Jennings RB. Myocyte swelling and plas-malemmal integrity during early experimental myocardial ischemia in vivo. Scanning Microsc 2: 477-484, 1988.
136. Sakata N, Ida T, Joshita T, and Ooneda G. Scanning and transmission electron microscopic study on the cerebral arterial endothelium of experimentally hypertensive rats fed an atherogenic diet. Acta Pathol Jpn 33: 1105-1113,1983.
137. Sanchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Perez-Vizcaino F, and Duarte J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24: 75-84, 2006.
138. Sargiacomo M, Scherer PE, Tang Z, Kübler E, Song KS, Sanders MC, and Lisanti MP. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 92: 9407-9411, 1995.
139. Sbaa E, Frerart F, and Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc Med 15: 157-162, 2005.
140. Scherer PE, Lewis RY, Volonté D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, and Lisanti MP. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo, J Biol Chem 272: 29337-29346, 1997.
141. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, and Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 270: 16395-16401, 1995.
142. Schlegel A and Lisanti MP. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. ] Biol Chem 275: 21605-21617, 2000.
143. Schmitz G and Grandl M. Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid Redox Signal 9: 1499-1518, 2007.
144. Schutz GJ, Kada G, Pastushenko VP, and Schindler H. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J 19: 892-901, 2000.
145. Severs NJ. Plasma membrane cholesterol in myocardial muscle and capillary endothelial cells. Distribution of filipin-induced deformations in freeze-fracture. Eur J Cell Biol 25: 289-299, 1981.
146. Shao D, Segal AW, and Dekker LV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 550: 101-106, 2003.
147. Sheets ED, Lee GM, Simson R, and Jacobson K. Transient confinement of a glycosylphosphatidylinositol-anchored protein in the plasma membrane. Biochemistry 36: 12449-12458, 1997.
148. Shevchuk AI, Hobson P, Lab MJ, Klenerman D, Krauze-wicz N, and Korchev YE. Endocytic pathways: Combined scanning ion conductance and surface confocal microscopy study. Pflugers Arch 456: 227-235, 2008.
149. Shinomura T, Nakao S, and Mori K. Reduction of depolarization-induced glutamate release by heme oxygenase inhibitor: possible role of carbon monoxide in synaptic transmission. Neurosci Lett 166: 131-134, 1994.
150. Siafakas AR, Wright LC, Sorrell TC, and Djordjevic JT. Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase Bl and Cu/Zn su-peroxide dismutase. Eukaryot Cell 5: 488-498, 2006.
151. Singer SJ and Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 175: 720-731, 1972.
152. Sotgia F, Minetti C, and Lisanti MP. Localization of the human caveolin-3 gene to the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene. Identification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome. FEBS Lett 452: 177-180,1999.
153. Sowa G, Pypaert M and Sessa WC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 98: 14072-14077, 2001.
154. Sprenger RR and Horrevoets AJ. Proteomic study of caveolae and rafts isolated from human endothelial cells. Methods Mol Biol 357: 199-213, 2007.
155. Sprenger RR and Horrevoets AJ. The ins and outs of lipid domain proteomics. Proteomics 7: 2895-2903, 2007.
156. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD, and Thompson TC. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 61: 3882-3885, 2001.
157. Tahir SA, Yang G, Goltsov AA, Watanabe M, Tabata K, Addai J, Fattah el MA, Kadmon D, and Thompson TC. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Res 68: 731-739, 2008.
158. Tomoiu A, Larbi A, Fortin C, Dupuis G, and Fulop T, Jr. Do membrane rafts contribute to human immunosenescence? Ann NY Acad Sci 1100: 98-110, 2007.
159. Tsutsumi Y, Horikawa Y, Jennings M, Kidd M, Niesman I, Yokoyama U, Head B, Hagiwara Y, Ishikawa Y, Miyano-hara A, Patel P, Insel P, Patel H, and Roth D. Increased expression of caveolin-3 promotes ischemic preconditioning. Circulation 118: 1979-1988, 2008.
160. Unno M, Matsui T, and Ikeda-Saito M. Structure and catalytic mechanism of heme oxygenase. Nat Prod Rep 24: 553-570, 2007.
161. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006: re8, 2006.
162. van der Loo B, Bachschmid M, Skepper JN, Labugger R, Schildknecht S, Hahn R, Mussig E, Gygi D, and Luscher TF. Age-associated cellular relocation of Sod 1 as a self-defense is a futile mechanism to prevent vascular aging. Biochem Biophys Res Commun 344: 972-980, 2006.
163. Venema VJ, Ju H, Zou R, and Venema RC. Interaction of neuronal
164. Vilhardt F and van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane micro-domains for assembly. EMBO J 23: 739-748, 2004.
165. Vinten J, Johnsen AH, Roepstorff P, Harpoth J, and Tranum-Jensen J. Identification of a major protein on the cytosolic face of caveolae. Biochim Biophys Acta 1717: 34-40, 2005.
166. Viola A and Gupta N. Tether and trap: regulation of membrane-raft dynamics by actin-binding proteins. Nat Rev Immunol 7: 889-896, 2007.
167. Volonte D, McTiernan CF, Drab M, Kasper M, and Galbiati F. Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis. Am J Physiol Heart Circ Physiol 294: H392-401, 2008.
168. Wang L, Sapuri-Butti AR, Aung HH, Parikh AN, and Rutledge JC. Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane micro-domains and produces reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H237-244, 2008.
169. Wang R, Wang Z, and Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol 121: 927-934, 1997.
170. Williams TM and Lisanti MP. The caveolin proteins. Genome Biol 5: 214, 2004.
171. Yamabhai M and Anderson RG. Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts. J Biol Chem 277: 24843-24846, 2002.
172. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1: 445-458, 1955.
173. Yang B and Rizzo V. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 292: H954-962, 2007.
174. Yoshizaki F, Nakayama H, Iwahara C, Takamori K, Ogawa H, and Iwabuchi K. Role of glycosphingolipid-enriched microdomains in innate immunity: microdomain-dependent phagocytic cell functions. Biochim Biophys Acta 1780: 383-392, 2008.
175. Zeng F, Watt NT, Walmsley AR, and Hooper NM. Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. J Neurochem 84: 480-490, 2003.
176. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E, and Li PL. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endo-thelial cells. Antioxid Redox Signal 9: 817-828, 2007.
177. Zhang AY, Yi F, Zhang G, Gulbins E, and Li PL. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 47: 74-80, 2006.
178. Zhuo M, Small SA, Kandel ER, and Hawkins RD. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science 260: 1946-1950, 1993.
179. Zidovetzki R and Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324, 2007.
180. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, and Alexander RW. Caveolin-1 is essential for activation of Racl and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: Role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25: 1824-1830, 2005.